Literature DB >> 12110488

Malignant mixed mesodermal tumours: biology and clinical aspects.

C Gourley1, A Al-Nafussi, M Abdulkader, J F Smyth, H Gabra.   

Abstract

Mixed mesodermal tumours (MMTs) are relatively rare gynaecological tumours that have been poorly studied in clinical and molecular terms. They are chemosensitive (at least initially), although ultimately they have a poor prognosis. The biology of the tumour is fascinating in view of its composition of both epithelial and mesenchymal entities. We review herein the literature on the clinical and biological aspects of this malignancy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110488     DOI: 10.1016/s0959-8049(02)00114-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Carcinosarcoma of the ovary: MR and clinical findings compared with high-grade serous carcinoma.

Authors:  Tsukasa Saida; Kensaku Mori; Yumiko Oishi Tanaka; Masafumi Sakai; Taishi Amano; Shunsuke Kikuchi; Souta Masuoka; Miki Yoshida; Tomohiko Masumoto; Toyomi Satoh; Manabu Minami
Journal:  Jpn J Radiol       Date:  2020-11-20       Impact factor: 2.374

2.  Sensitivities of Uterine Adenocarcinoma, Mixed Mullerian Tumor (MMT) and Sarcoma Cell Lines to Chemotherapeutic Agents and a Flex-Het Drug.

Authors:  Johnny Hyde; Doris M Benbrook
Journal:  Am J Pharmacol Toxicol       Date:  2006-01-01

3.  Concurrent diagnosis of pulmonary metastasis of malignant mixed müllerian tumor and small cell lung cancer.

Authors:  Young Jin Lee; Eun Joo Jung; Seung Heon Lee; Young-Min Lee; Bomi Kim; Seok Jin Choi; Dae Hoon Jeong; Hyun-Kyung Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-07-31

Review 4.  Cervical Carcinosarcoma: Current Understanding on Pathogenesis, Diagnosis, Management and Future Perspectives.

Authors:  Xinyao Shu; Yuwen Zhou; Guixia Wei; Xiaorong Chen; Meng Qiu
Journal:  Clin Med Insights Oncol       Date:  2021-12-08

5.  Prognostic significance of lymph node metastasis and lymphadenectomy in early-stage ovarian carcinosarcoma.

Authors:  Wen-Peng Wang; Ning Li; Yuan-Yuan Zhang; Yu-Tao Gao; Yang-Chun Sun; Li Ge; Ling-Ying Wu
Journal:  Cancer Manag Res       Date:  2018-07-10       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.